These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 23434054)
1. Frequency of fibroblast growth factor receptor 1 gene amplification in oral tongue squamous cell carcinomas and associations with clinical features and patient outcome. Young RJ; Lim AM; Angel C; Collins M; Deb S; Corry J; Wiesenfeld D; Kleid S; Sigston E; Lyons B; Russell PA; Wright G; McArthur GA; Fox SB; Rischin D; Solomon B Oral Oncol; 2013 Jun; 49(6):576-81. PubMed ID: 23434054 [TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor receptor 1 gene amplification is associated with poor survival and cigarette smoking dosage in patients with resected squamous cell lung cancer. Kim HR; Kim DJ; Kang DR; Lee JG; Lim SM; Lee CY; Rha SY; Bae MK; Lee YJ; Kim SH; Ha SJ; Soo RA; Chung KY; Kim JH; Lee JH; Shim HS; Cho BC J Clin Oncol; 2013 Feb; 31(6):731-7. PubMed ID: 23182986 [TBL] [Abstract][Full Text] [Related]
3. FGFR1 Amplification in Squamous Cell Carcinoma of the Lung with Correlation of Primary and Metastatic Tumor Status. Monaco SE; Rodriguez EF; Mahaffey AL; Dacic S Am J Clin Pathol; 2016 Jan; 145(1):55-61. PubMed ID: 26712871 [TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor receptor-1 as a potential therapeutic target in sinonasal cancer. Schröck A; Göke F; Wagner P; Bode M; Franzen A; Huss S; Agaimy A; Ihrler S; Kirsten R; Kristiansen G; Bootz F; Lengerke C; Perner S Head Neck; 2014 Sep; 36(9):1253-7. PubMed ID: 23913758 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value of fibroblast growth factor receptor 1 gene locus amplification in resected lung squamous cell carcinoma. Craddock KJ; Ludkovski O; Sykes J; Shepherd FA; Tsao MS J Thorac Oncol; 2013 Nov; 8(11):1371-7. PubMed ID: 24077455 [TBL] [Abstract][Full Text] [Related]
6. FGFR1 Amplification Is Often Homogeneous and Strongly Linked to the Squamous Cell Carcinoma Subtype in Esophageal Carcinoma. von Loga K; Kohlhaussen J; Burkhardt L; Simon R; Steurer S; Burdak-Rothkamm S; Jacobsen F; Sauter G; Krech T PLoS One; 2015; 10(11):e0141867. PubMed ID: 26555375 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of fibroblast growth factor receptor 1 (FGFR1) amplification in squamous cell carcinomas of the head and neck. Clauditz TS; Böttcher A; Hanken H; Borgmann K; Sauter G; Wilczak W; Grob T; Münscher A J Cancer Res Clin Oncol; 2018 Jan; 144(1):53-61. PubMed ID: 29022097 [TBL] [Abstract][Full Text] [Related]
8. Association Between Fibroblast Growth Factor Receptor 1 Gene Amplification and Human Papillomavirus Prevalence in Tonsillar Squamous Cell Carcinoma With Clinicopathologic Analysis. Park S; Lee M; Cho KJ; Kim SB; Roh JL; Choi SH; Nam SY; Kim SY; Song JS J Histochem Cytochem; 2018 Jul; 66(7):511-522. PubMed ID: 29553868 [TBL] [Abstract][Full Text] [Related]
9. High rate of FGFR1 amplifications in brain metastases of squamous and non-squamous lung cancer. Preusser M; Berghoff AS; Berger W; Ilhan-Mutlu A; Dinhof C; Widhalm G; Dieckmann K; Wöhrer A; Hackl M; von Deimling A; Streubel B; Birner P Lung Cancer; 2014 Jan; 83(1):83-9. PubMed ID: 24183471 [TBL] [Abstract][Full Text] [Related]
10. Recurrent FGFR1 amplification and high FGFR1 protein expression in oral squamous cell carcinoma (OSCC). Freier K; Schwaenen C; Sticht C; Flechtenmacher C; Mühling J; Hofele C; Radlwimmer B; Lichter P; Joos S Oral Oncol; 2007 Jan; 43(1):60-6. PubMed ID: 16807070 [TBL] [Abstract][Full Text] [Related]
11. FGFR1 amplification in squamous cell carcinoma of the lung. Heist RS; Mino-Kenudson M; Sequist LV; Tammireddy S; Morrissey L; Christiani DC; Engelman JA; Iafrate AJ J Thorac Oncol; 2012 Dec; 7(12):1775-1780. PubMed ID: 23154548 [TBL] [Abstract][Full Text] [Related]
12. Low prognostic implication of fibroblast growth factor family activation in triple-negative breast cancer subsets. Lee HJ; Seo AN; Park SY; Kim JY; Park JY; Yu JH; Ahn JH; Gong G Ann Surg Oncol; 2014 May; 21(5):1561-8. PubMed ID: 24385208 [TBL] [Abstract][Full Text] [Related]
13. Programmed cell death-ligand 1 (PD-L1) expression and fibroblast growth factor receptor 1 (FGFR1) amplification in stage III/IV lung squamous cell carcinoma (SQC). Guo Q; Sun Y; Yu S; Bai H; Zhao J; Zhuo M; Wang J Thorac Cancer; 2017 Mar; 8(2):73-79. PubMed ID: 28008744 [TBL] [Abstract][Full Text] [Related]
14. Prevalence, morphology, and natural history of FGFR1-amplified lung cancer, including squamous cell carcinoma, detected by FISH and SISH. Russell PA; Yu Y; Young RJ; Conron M; Wainer Z; Alam N; Solomon B; Wright GM Mod Pathol; 2014 Dec; 27(12):1621-31. PubMed ID: 24762544 [TBL] [Abstract][Full Text] [Related]
15. The frequency and impact of FGFR1 amplification on clinical outcomes in Korean patients with small cell lung cancer. Park JS; Lee JS; Kim EY; Jung JY; Kim SK; Chang J; Kim DJ; Lee CY; Jung I; Kim JH; Kim HR; Moon YW; Kim HS; Cho BC; Shim HS Lung Cancer; 2015 Jun; 88(3):325-31. PubMed ID: 25819384 [TBL] [Abstract][Full Text] [Related]
16. Rationale for treatment of metastatic squamous cell carcinoma of the lung using fibroblast growth factor receptor inhibitors. Göke F; Franzen A; Menon R; Goltz D; Kirsten R; Boehm D; Vogel W; Göke A; Scheble V; Ellinger J; Gerigk U; Fend F; Wagner P; Schroeck A; Perner S Chest; 2012 Oct; 142(4):1020-1026. PubMed ID: 22499828 [TBL] [Abstract][Full Text] [Related]